US Federal 2025-2026 Regular Session

US Federal House Bill HB5485

Introduced
9/18/25  

Caption

Second Chance at Life Act of 2025

Impact

The bill aims to significantly impact existing abortion laws by instituting new informed consent requirements and potentially altering the landscape of reproductive options available to women. By facilitating access to information about abortion reversal, supporters argue that it empowers women with choices post-consultation. The introduction of this bill adds another layer of regulation to chemical abortions, which could revise women's healthcare practices and protocols across states, as compliance will be necessary for abortion providers dealing with interstate or foreign commerce.

Summary

House Bill 5485, titled the 'Second Chance at Life Act of 2025', proposes to ensure that women seeking a chemical abortion are informed about the potential to reverse the procedure if they change their minds. The bill mandates that abortion providers must inform patients at least 24 hours in advance about the possibility of reversing a mifepristone-induced chemical abortion. This provision is particularly focused on the two-drug process of abortion involving mifepristone and misoprostol, emphasizing that time is of the essence for reversal options. The bill also envisions creating a dedicated website to provide resources and assistance regarding the reversal process, as well as printed materials in various languages accessible by the public as part of informed consent requirements.

Contention

Debate surrounding HB 5485 is expected to focus on various points of contention, including the scientific validity of abortion reversal claims and the implications it may hold for women's autonomy over their reproductive health decisions. Proponents argue that the bill provides essential information that could lead to changes of heart, while opponents express concern that this legislation could propagate misinformation about the safety and effectiveness of reversal methods. Furthermore, the requirement of written disclosures and the posting of signs in clinics are viewed by critics as potentially stigmatizing for women seeking abortions, infringing on their rights and privacy.

Companion Bills

No companion bills found.

Previously Filed As

US HB797

Ultrasounds Save Lives Act of 2025

US HB783

Regards notice of possibility of reversing a chemical abortion

US HB796

Second Chance for Moms Act

US HB729

Teleabortion Prevention Act of 2025

US HB629

Ending Chemical Abortions Act of 2025

US HB682

Heartbeat Protection Act of 2025

US HB7983

Clean Water for All Life Act

US HB632

Protecting Life on College Campus Act of 2025

US H804

Human Life Protection Act of 2025

US HB2226

Let Pregnancy Centers Serve Act of 2025

Similar Bills

No similar bills found.